Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bingzhi Injury Pain Aerosol in Acute Closed Soft Tissue Injury
CTR20150132Phase 2Active
- Sponsor
- Guizhou Antai Pharmaceutical
- Start
- May 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Bingzhi Shangtong in soft tissue injury, Ankle sprain, knee sprain, sprain, superficial partial-thickness burn, sponsored by Guizhou Antai Pharmaceutical. Started May 2015; status: active.
02
Drugs
Bingzhi Shangtong
03
Conditions
soft tissue injuryAnkle sprainknee sprainsprainsuperficial partial-thickness burn
Beyond the preview
Go deeper on CTR20150132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150132.